According to Charles River Laboratories 's latest financial reports the company's current EPS (TTM) is $15.09. In 2022 the company made an earnings per share (EPS) of $15.22 an increase over its 2021 EPS that were of $12.35.
Year | EPS | Change |
---|---|---|
2023 (TTM) | $14.19 | -6.76% |
2022 | $15.22 | 23.17% |
2021 | $12.35 | 5.86% |
2020 | $11.67 | 41.97% |
2019 | $8.22 | 10% |
2018 | $7.47 | 81.47% |
2017 | $4.12 | -21.52% |
2016 | $5.25 | 2.8% |
2015 | $5.10 | 18.45% |
2014 | $4.31 | 25.46% |
2013 | $3.43 | 6.4% |
2012 | $3.23 | -5.58% |
2011 | $3.42 | -139.81% |
2010 | -$8.59 | -406.82% |
2009 | $2.80 | -122.68% |
2008 | -$12.34 | -435.93% |
2007 | $3.67 | 131% |
2006 | $1.59 | -50.98% |
2005 | $3.24 | 12.71% |
2004 | $2.88 | 2.84% |
2003 | $2.80 | 57.14% |
2002 | $1.78 | 31.76% |
2001 | $1.35 | -2933.33% |
2000 | -$0.04770 |